キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/01/28 | 2,275 | 2,300 | 2,260 | 2,300 | +84 | +3.8% | 94,400 |
2022/01/27 | 2,251 | 2,258 | 2,201 | 2,216 | -37 | -1.6% | 78,000 |
2022/01/26 | 2,298 | 2,298 | 2,251 | 2,253 | -45 | -2% | 49,600 |
2022/01/25 | 2,310 | 2,320 | 2,279 | 2,298 | -39 | -1.7% | 69,700 |
2022/01/24 | 2,273 | 2,337 | 2,273 | 2,337 | +49 | +2.1% | 54,900 |
2022/01/21 | 2,299 | 2,299 | 2,274 | 2,288 | -1 | ±0% | 63,300 |
2022/01/20 | 2,259 | 2,309 | 2,250 | 2,289 | +43 | +1.9% | 86,200 |
2022/01/19 | 2,290 | 2,299 | 2,240 | 2,246 | -69 | -3% | 90,600 |
2022/01/18 | 2,388 | 2,388 | 2,314 | 2,315 | +2 | +0.1% | 69,900 |
2022/01/17 | 2,312 | 2,315 | 2,287 | 2,313 | +43 | +1.9% | 58,300 |
2022/01/14 | 2,300 | 2,300 | 2,242 | 2,270 | -4 | -0.2% | 69,000 |
2022/01/13 | 2,308 | 2,308 | 2,273 | 2,274 | -27 | -1.2% | 52,200 |
2022/01/12 | 2,278 | 2,321 | 2,263 | 2,301 | +55 | +2.4% | 61,300 |
2022/01/11 | 2,237 | 2,271 | 2,223 | 2,246 | +3 | +0.1% | 60,000 |
2022/01/07 | 2,253 | 2,272 | 2,221 | 2,243 | +12 | +0.5% | 96,500 |
2022/01/06 | 2,271 | 2,305 | 2,230 | 2,231 | -56 | -2.4% | 75,600 |
2022/01/05 | 2,295 | 2,299 | 2,277 | 2,287 | +10 | +0.4% | 86,800 |
2022/01/04 | 2,254 | 2,285 | 2,250 | 2,277 | +23 | +1% | 122,400 |
2021/12/30 | 2,250 | 2,267 | 2,242 | 2,254 | +1 | ±0% | 26,000 |
2021/12/29 | 2,250 | 2,274 | 2,242 | 2,253 | +1 | ±0% | 38,300 |
2021/12/28 | 2,246 | 2,255 | 2,231 | 2,252 | +9 | +0.4% | 46,700 |
2021/12/27 | 2,274 | 2,274 | 2,232 | 2,243 | -35 | -1.5% | 31,900 |
2021/12/24 | 2,281 | 2,298 | 2,265 | 2,278 | +4 | +0.2% | 77,200 |
2021/12/23 | 2,254 | 2,285 | 2,241 | 2,274 | +28 | +1.2% | 47,400 |
2021/12/22 | 2,246 | 2,250 | 2,226 | 2,246 | +21 | +0.9% | 55,100 |
2021/12/21 | 2,233 | 2,240 | 2,219 | 2,225 | +25 | +1.1% | 42,100 |
2021/12/20 | 2,218 | 2,232 | 2,197 | 2,200 | -36 | -1.6% | 31,200 |
2021/12/17 | 2,258 | 2,265 | 2,225 | 2,236 | -12 | -0.5% | 50,300 |
2021/12/16 | 2,250 | 2,259 | 2,228 | 2,248 | +35 | +1.6% | 50,900 |
2021/12/15 | 2,227 | 2,252 | 2,213 | 2,213 | -33 | -1.5% | 48,300 |
2021/12/14 | 2,222 | 2,249 | 2,208 | 2,246 | +41 | +1.9% | 60,900 |
2021/12/13 | 2,194 | 2,218 | 2,185 | 2,205 | +65 | +3% | 95,500 |
2021/12/10 | 2,183 | 2,187 | 2,132 | 2,140 | -48 | -2.2% | 64,500 |
2021/12/09 | 2,224 | 2,229 | 2,185 | 2,188 | -36 | -1.6% | 37,200 |
2021/12/08 | 2,216 | 2,246 | 2,213 | 2,224 | +8 | +0.4% | 71,000 |
2021/12/07 | 2,184 | 2,217 | 2,176 | 2,216 | +34 | +1.6% | 95,400 |
2021/12/06 | 2,200 | 2,224 | 2,178 | 2,182 | -34 | -1.5% | 64,500 |
2021/12/03 | 2,187 | 2,224 | 2,165 | 2,216 | +31 | +1.4% | 95,300 |
2021/12/02 | 2,200 | 2,240 | 2,182 | 2,185 | -35 | -1.6% | 102,800 |
2021/12/01 | 2,276 | 2,276 | 2,211 | 2,220 | -64 | -2.8% | 177,700 |
2021/11/30 | 2,231 | 2,284 | 2,231 | 2,284 | +68 | +3.1% | 306,600 |
2021/11/29 | 2,188 | 2,253 | 2,179 | 2,216 | +13 | +0.6% | 152,500 |
2021/11/26 | 2,228 | 2,228 | 2,198 | 2,203 | -41 | -1.8% | 75,200 |
2021/11/25 | 2,234 | 2,244 | 2,210 | 2,244 | +9 | +0.4% | 106,000 |
2021/11/24 | 2,250 | 2,258 | 2,217 | 2,235 | +1 | ±0% | 84,000 |
2021/11/22 | 2,205 | 2,247 | 2,191 | 2,234 | +11 | +0.5% | 95,100 |
2021/11/19 | 2,206 | 2,227 | 2,196 | 2,223 | -19 | -0.8% | 202,000 |
2021/11/18 | 2,260 | 2,279 | 2,232 | 2,242 | -25 | -1.1% | 65,200 |
2021/11/17 | 2,333 | 2,369 | 2,267 | 2,267 | -65 | -2.8% | 66,100 |
2021/11/16 | 2,379 | 2,379 | 2,328 | 2,332 | -48 | -2% | 50,000 |
801~
850
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 415,500円 | +3.6% | +6.1% | 2.89% | 14.46倍 | 0.85倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
日本新薬 | 336,300円 | +8.0% | -15.3% | 3.69% | 9.44倍 | 0.92倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サワイGHD | 199,000円 | +4.0% | +25.4% | 2.66% | 8.70倍 | 1.14倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
科研薬 | 401,000円 | +30.5% | +111.0% | 4.74% | 11.30倍 | 0.98倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム